597 related articles for article (PubMed ID: 32696883)
1. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and its implications for thrombosis and anticoagulation.
Connors JM; Levy JH
Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
[TBL] [Abstract][Full Text] [Related]
3. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
5. [Research progress of coagulation dysfunction in coronavirus disease 2019].
Zhong S; Wu F; Peng N; Xie Q; Song J; Li W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1135-1138. PubMed ID: 33081906
[TBL] [Abstract][Full Text] [Related]
6. Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19).
Guevara-Noriega KA; Lucar-Lopez GA; Nuñez G; Rivera-Aguasvivas L; Chauhan I
Ann Clin Lab Sci; 2020 May; 50(3):295-298. PubMed ID: 32581015
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
Ornelas-Ricardo D; Jaloma-Cruz AR
Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.
Bhattacharjee S; Banerjee M; Pal R
Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
Zhang Y; Cao W; Xiao M; Li YJ; Yang Y; Zhao J; Zhou X; Jiang W; Zhao YQ; Zhang SY; Li TS
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):302-307. PubMed ID: 32447934
[No Abstract] [Full Text] [Related]
11. D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury: A case series.
Wang X; Du B; Li J; Wang S; Wang X; Guo M; Yang B; Si D; Bai O
Medicine (Baltimore); 2020 Jul; 99(31):e21513. PubMed ID: 32756189
[TBL] [Abstract][Full Text] [Related]
12. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
Salamanna F; Maglio M; Landini MP; Fini M
Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
[TBL] [Abstract][Full Text] [Related]
13. D-dimer is associated with the risk of mortality in Coronavirus Disease 2019 patients.
Shi L; Wang Y; Wang YD; Duan GC; Yang HY
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8576-8579. PubMed ID: 32894563
[TBL] [Abstract][Full Text] [Related]
14. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
Han H; Yang L; Liu R; Liu F; Wu KL; Li J; Liu XH; Zhu CL
Clin Chem Lab Med; 2020 Jun; 58(7):1116-1120. PubMed ID: 32172226
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.
Trigonis RA; Holt DB; Yuan R; Siddiqui AA; Craft MK; Khan BA; Kapoor R; Rahman O
Crit Care Med; 2020 Sep; 48(9):e805-e808. PubMed ID: 32618699
[TBL] [Abstract][Full Text] [Related]
16. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study.
Alonso-Fernández A; Toledo-Pons N; Cosío BG; Millán A; Calvo N; Ramón L; de Mendoza SH; Morell-García D; Bauça-Rossello JM; Núñez B; Pons J; Palmer JA; Martín L; Peñaranda M; Pou JA; Sauleda J; Sala-Llinas E
PLoS One; 2020; 15(8):e0238216. PubMed ID: 32841275
[TBL] [Abstract][Full Text] [Related]
18. Thromboinflammatory response in SARS-CoV-2 sepsis.
Maiese A; Passaro G; Matteis A; Fazio V; Raffaele R; Paolo MD
Med Leg J; 2020 Jul; 88(2):78-80. PubMed ID: 32490726
[TBL] [Abstract][Full Text] [Related]
19. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
20. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.
Giannis D; Ziogas IA; Gianni P
J Clin Virol; 2020 Jun; 127():104362. PubMed ID: 32305883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
